Explore Novel Strategies on Virology
Journal of Antivirals and Antiretrovirals is a peer-reviewed Journal, encourages on-going international research and information exchange through publication of latest advances.
The Journal is pleased to inform that it is been running successfully since 11 years and is running towards its 12th Anniversery. It is an Open access scholarly Health Science journal with an ISSN No: 1948-5964. This journal is known for its quality research articles in the field of AIDS Antiretroviral Therapy, Antiretrovirals, Antivirals, Bacteriophages, Clinical Virology, Combination Therapy, Cross Infection Control, Emerging Viral Diseases, H1N1, HIV, Interferons (IFNs), Protease Inhibitors, Retrovirology, Viral Immunity, Viral Vaccine, Viral Vectors. The journal is indexed in Index Copernicus having a value of 108.6.
The primary current therapeutic approach against viral diseases is to target viral components that are essential for replication. There are a number of disadvantages targeting viral components including the limited number of druggable viral targets because viruses have a small genome, as well as the rapid development of drug resistance. New drug therapies combine antivirals to increase efficacy and to avoid the development of drug resistant strains. These strategies are effective for viruses such as HIV, but clearly there is a need to expand our drug arsenal to address the wide diversity of viruses. This pathway relies on alternative strategies for drug discovery, such as examining the virus-host interface.